Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Maternal & Fetal Health

Our Maternal & Fetal Health research covers the following research groups: Lactation, Intelligent Imaging in Fetal Health, the Clinical Research Group, Oxford Labour Monitoring, Placental Imaging and Pre-eclampsia.

Our Maternal & Fetal Health research covers the following research groups: Fetal Monitoring; Lactation and Breastfeeding, The Oxford Safer Pregnancy Alliance (OSPREA), the INGR1D Study and Pre-eclampsia. © Copyright: Shutterstock

The Maternal and Fetal Health theme core aims are to advance scientific knowledge, enhance clinical practices, and foster international collaboration across the spectrum of maternal and fetal health.



Topics in this theme

Antepartum Monitoring
Antepartum Monitoring
Intelligent Imaging in Fetal Health
Intelligent Imaging in Fetal Health
Lactation
Lactation
With MuM-PreDiCT we aim to provide deeper understanding of what makes some pregnant women more likely to have two or more long-term health conditions and how this affects them and their children.
MuM-PreDiCT
NDWRH Clinical Research Group
NDWRH Clinical Research Group
Oxford Labour Monitoring
Oxford Labour Monitoring
OxGRIP – Oxford Growth Restriction Identification Programme
OxGRIP – Oxford Growth Restriction Identification Programme
The placenta is the most indispensable, disposable organ you ever had. It decrees both how well we grow and develop in the womb and our future health well into adulthood. Our research explores two key themes: 1) Imaging the placenta early in pregnancy in order to predict adverse pregnancy outcomes including fetal growth restriction and 2) Diagnosis and management of Placenta Accreta Spectrum Disorder (PAS) - also known as abnormally invasive placenta (AIP).
Placental Imaging
Pre-eclampsia affects 5% of pregnant women, usually during the second half of pregnancy (from around 20 weeks) or soon after their baby is delivered. It is associated with significant problems in the mother and the baby. Our research examines the molecular mechanisms of pre-eclampsia and explores if we can predict and prevent this disease.
Pre-eclampsia